WEZENLA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Amgen Technology (Ireland) Unlimited Company🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a897e18ff8217b78
Drug Cima Aemps Name: WEZENLA 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1241823004
Holder Company Name: Amgen Technology (Ireland) Unlimited Company
Marketing Company Name: Amgen S.A.
Holder Company Detail Path: /organization/amgen-technology-ireland-unlimited-company
Marketing Company Detail Path: /organization/amgen-sa
Authorization Date: 2024-06-26
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 130 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Amgen Technology (Ireland) Unlimited Company
Company Detail Path: /organization/amgen-technology-ireland-unlimited-company

USTEKINUMAB

90 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 26, 2024

Approval ID

a897e18ff8217b78

Type

Standard